Beaton Management Co. Inc. lowered its holdings in shares of Aetna Inc (NYSE:AET) by 7.2% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,521 shares of the company’s stock after selling 350 shares during the quarter. Beaton Management Co. Inc.’s holdings in Aetna were worth $830,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of AET. Rockefeller Capital Management L.P. purchased a new position in Aetna during the 1st quarter valued at $578,000. Pegasus Partners Ltd. boosted its holdings in Aetna by 16.2% during the 1st quarter. Pegasus Partners Ltd. now owns 10,001 shares of the company’s stock valued at $1,690,000 after acquiring an additional 1,397 shares during the period. Pictet & Cie Europe SA boosted its holdings in Aetna by 31.8% during the 1st quarter. Pictet & Cie Europe SA now owns 8,356 shares of the company’s stock valued at $1,412,000 after acquiring an additional 2,018 shares during the period. KBC Group NV boosted its holdings in Aetna by 34.5% during the 1st quarter. KBC Group NV now owns 392,343 shares of the company’s stock valued at $66,306,000 after acquiring an additional 100,576 shares during the period. Finally, Fort L.P. purchased a new position in Aetna during the 1st quarter valued at $894,000. Institutional investors own 83.51% of the company’s stock.
A number of equities analysts recently issued reports on AET shares. Cantor Fitzgerald restated a “buy” rating and set a $202.00 price objective on shares of Aetna in a report on Thursday, August 2nd. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research report on Tuesday, June 26th. Finally, Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a research report on Monday, August 6th. Eight research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Aetna currently has an average rating of “Hold” and an average target price of $200.38.
AET opened at $202.75 on Monday. The firm has a market capitalization of $66.60 billion, a PE ratio of 20.56, a P/E/G ratio of 1.75 and a beta of 0.68. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.74 and a quick ratio of 0.74. Aetna Inc has a 12 month low of $149.69 and a 12 month high of $204.20.
Aetna (NYSE:AET) last released its quarterly earnings results on Thursday, August 2nd. The company reported $3.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.04 by $0.39. The firm had revenue of $15.56 billion during the quarter, compared to analyst estimates of $15.59 billion. Aetna had a return on equity of 20.66% and a net margin of 5.77%. The business’s revenue for the quarter was up .2% compared to the same quarter last year. During the same period in the previous year, the company posted $3.42 EPS. research analysts expect that Aetna Inc will post 11.31 earnings per share for the current year.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Read More: What Is An Exchange-Traded Fund (ETF)?
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.